G1 Therapeutics
Why Robinhood?
You can watch GTHX and buy or sell other stocks, ETFs, and their options commission-free!About GTHX
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib.
GTHX Key Statistics
Stock Snapshot
The current G1 Therapeutics(GTHX) stock price is $7.15, with a market capitalization of 377.22M. The stock trades at a price-to-earnings (P/E) ratio of -8.30.
On 2026-04-01, G1 Therapeutics(GTHX) stock opened at —, reached a high of —, and a low of —.
G1 Therapeutics(GTHX) shares are trading with a volume of 0, against a daily average of 651.38K.
In the last year, G1 Therapeutics(GTHX) shares hit a 52-week high of $7.19 and a 52-week low of $1.08.
In the last year, G1 Therapeutics(GTHX) shares hit a 52-week high of $7.19 and a 52-week low of $1.08.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.